JAK2 and metastatic malignant neoplasm: In line with the observations of HeLa cells, deletion of JAK2 in human cancers was associated with increased genome alterations (pan-cancer, n = 10939) (Fig. 7A), and alterations of JAK2, including deep deletion, amplification, and mutations, were found in a spectrum of human metastatic cancers (Fig. S10A).